tremelimumab,durvalumab
astrazeneca
[]
preview of the future for loco regional dmmr/msi-high #gea by at #gi23 . needs to test our non-met patients. infinity trial. nice design. 
GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School